The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
A historical overview of protein kinases and their targeted small molecule inhibitors
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Initial sequencing and comparative analysis of the mouse genome
Mouse Genome Sequencing Consortium (2002) · Nature · doi:10.1038/nature01262 · Cited by 7,187
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
Soda, M., Choi, Y. L., Enomoto, M., Takada, S., Yamashita, Y., Ishikawa, S., Fujiwara, S.-I., Watanabe, H., Kurashina, K., Hatanaka, H., et al. (2007) · Nature · doi:10.1038/nature05945 · Cited by 5,439
The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains
Hanks, S. K., Quinn, A. M., & Hunter, T. (1988) · Science · doi:10.1126/science.3291115 · Cited by 5,039
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,490
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Kwak, E. L., Bang, Y.-J., Camidge, D. R., Shaw, A. T., Solomon, B., Maki, R. G., Ou, S.-H. I., Dezube, B. J., Jänne, P. A., Costa, D. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006448 · Cited by 4,446
ROWLEY, J. D. (1973) · Nature · doi:10.1038/243290a0 · Cited by 4,291
Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks
Olsen, J. V., Blagoev, B., Gnad, F., Macek, B., Kumar, C., Mortensen, P., & Mann, M. (2006) · Cell · doi:10.1016/j.cell.2006.09.026 · Cited by 3,499
Morgan, D. O. (1995) · Nature · doi:10.1038/374131a0 · Cited by 3,284
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. B. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 2,967
Epidermal growth factor-related peptides and their receptors in human malignancies
Salomon, D. S., Brandt, R., Ciardiello, F., & Normanno, N. (1995) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(94)00144-i · Cited by 2,690
Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences
Downward, J., Yarden, Y., Mayes, E., Scrace, G., Totty, N., Stockwell, P., Ullrich, A., Schlessinger, J., & Waterfield, M. D. (1984) · Nature · doi:10.1038/307521a0 · Cited by 2,516
Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
Rosell, R., Moran, T., Queralt, C., Porta, R., Cardenal, F., Camps, C., Majem, M., Lopez-Vivanco, G., Isla, D., Provencio, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904554 · Cited by 2,373
Transforming gene product of Rous sarcoma virus phosphorylates tyrosine
Hunter, T., & Sefton, B. M. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1311 · Cited by 2,332
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
Heinrich, M. C., Corless, C. L., Demetri, G. D., Blanke, C. D., von Mehren, M., Joensuu, H., McGreevey, L. S., Chen, C.-J., Van den Abbeele, A. D., Druker, B. J., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.190 · Cited by 2,299
Giard, D. J., Aaronson, S. A., Todaro, G. J., Arnstein, P., Kersey, J. H., Dosik, H., & Parks, W. P. (1973) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/51.5.1417 · Cited by 2,289
Allosteric proteins and cellular control systems
Monod, J., Changeux, J.-P., & Jacob, F. (1963) · Journal of Molecular Biology · doi:10.1016/s0022-2836(63)80091-1 · Cited by 2,233
Protein kinases — the major drug targets of the twenty-first century?
Cohen, P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd773 · Cited by 2,186
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
Yun, C.-H., Mengwasser, K. E., Toms, A. V., Woo, M. S., Greulich, H., Wong, K.-K., Meyerson, M., & Eck, M. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709662105 · Cited by 2,118
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
Kantarjian, H., Sawyers, C., Hochhaus, A., Guilhot, F., Schiffer, C., Gambacorti-Passerini, C., Niederwieser, D., Resta, D., Capdeville, R., Zoellner, U., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011573 · Cited by 2,019
Protein Tyrosine Phosphatases in the Human Genome
Alonso, A., Sasin, J., Bottini, N., Friedberg, I., Friedberg, I., Osterman, A., Godzik, A., Hunter, T., Dixon, J., & Mustelin, T. (2004) · Cell · doi:10.1016/j.cell.2004.05.018 · Cited by 1,886
The resurgence of covalent drugs
Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3410 · Cited by 1,873
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
Schindler, T., Bornmann, W., Pellicena, P., Miller, W. T., Clarkson, B., & Kuriyan, J. (2000) · Science · doi:10.1126/science.289.5486.1938 · Cited by 1,780
Knighton, D. R., Zheng, J., Ten Eyck, L. F., Ashford, V. A., Xuong, N.-H., Taylor, S. S., & Sowadski, J. M. (1991) · Science · doi:10.1126/science.1862342 · Cited by 1,759
The Conformational Plasticity of Protein Kinases
Huse, M., & Kuriyan, J. (2002) · Cell · doi:10.1016/s0092-8674(02)00741-9 · Cited by 1,752
ERK1/2 MAP kinases: Structure, function, and regulation
Roskoski, R. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.04.005 · Cited by 1,650
Self-citationCarpenter, G., & Cohen, S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38983-5 · Cited by 1,622
Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22
GROFFEN, J., STEPHENSON, J., HEISTERKAMP, N., DEKLEIN, A., BARTRAM, C., & GROSVELD, G. (1984) · Cell · doi:10.1016/0092-8674(84)90077-1 · Cited by 1,599
Graus-Porta, D. (1997) · The EMBO Journal · doi:10.1093/emboj/16.7.1647 · Cited by 1,590
An Adenosine 3′,5′-Monophosphate-dependant Protein Kinase from Rabbit Skeletal Muscle
Walsh, D. A., Perkins, J. P., & Krebs, E. G. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)34204-8 · Cited by 1,445
Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug
Capdeville, R., Buchdunger, E., Zimmermann, J., & Matter, A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd839 · Cited by 1,389
The ErbB/HER family of protein-tyrosine kinases and cancer
Roskoski, R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2013.11.002 · Cited by 1,353
Self-citationDiscovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
Tsai, J., Lee, J. T., Wang, W., Zhang, J., Cho, H., Mamo, S., Bremer, R., Gillette, S., Kong, J., Haass, N. K., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711741105 · Cited by 1,346
Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers
Katayama, R., Shaw, A. T., Khan, T. M., Mino-Kenudson, M., Solomon, B. J., Halmos, B., Jessop, N. A., Wain, J. C., Yeo, A. T., Benes, C., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003316 · Cited by 1,309
Biology of Gastrointestinal Stromal Tumors
Corless, C. L., Fletcher, J. A., & Heinrich, M. C. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.140 · Cited by 1,224
EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors
Choi, Y. L., Soda, M., Yamashita, Y., Ueno, T., Takashima, J., Nakajima, T., Yatabe, Y., Takeuchi, K., Hamada, T., Haruta, H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007478 · Cited by 1,189
Ushiro, H., & Cohen, S. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43497-7 · Cited by 1,169
Zafar, S. Y., Peppercorn, J. M., Schrag, D., Taylor, D. H., Goetzinger, A. M., Zhong, X., & Abernethy, A. P. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0279 · Cited by 1,130
FRACTIONATION AND CHARACTERIZATION OF A CYCLIC ADENINE RIBONUCLEOTIDE FORMED BY TISSUE PARTICLES
Sutherland, E. W., & Rall, T. W. (1958) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77423-7 · Cited by 1,076
Heinrich, M. C., Griffith, D. J., Druker, B. J., Wait, C. L., Ott, K. A., & Zigler, A. J. (2000) · Blood · doi:10.1182/blood.v96.3.925 · Cited by 1,071
Anderson, N. G., Maller, J. L., Tonks, N. K., & Sturgill, T. W. (1990) · Nature · doi:10.1038/343651a0 · Cited by 1,063
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics
Arteaga, C. L., & Engelman, J. A. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.025 · Cited by 1,048
Tzahar, E., Waterman, H., Chen, X., Levkowitz, G., Karunagaran, D., Lavi, S., Ratzkin, B. J., & Yarden, Y. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5276 · Cited by 1,036
Acetylation of prostaglandin synthase by aspirin.
Roth, G. J., Stanford, N., & Majerus, P. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.8.3073 · Cited by 1,009
Knighton, D. R., Zheng, J., Ten Eyck, L. F., Xuong, N.-H., Taylor, S. S., & Sowadski, J. M. (1991) · Science · doi:10.1126/science.1862343 · Cited by 960
Nagar, B., Bornmann, W. G., Pellicena, P., Schindler, T. H., Veach, D. R., Miller, W. T., Clarkson, B. D., & Kuriyan, J. (2002) · PubMed · Cited by 923
Inoue, M., Kishimoto, A., Takai, Y., & Nishizuka, Y. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41010-6 · Cited by 862
BindingDB (2025) · PubMed · doi:10.7270/q2dr317m · Cited by 843
FORMATION OF A CYCLIC ADENINE RIBONUCLEOTIDE BY TISSUE PARTICLES
Rall, T. W., & Sutherland, E. W. (1958) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77422-5 · Cited by 831
Roskoski, R. (1983) · Methods in Enzymology · doi:10.1016/0076-6879(83)99034-1 · Cited by 824
Self-citationA native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles.
Cohen, S., Ushiro, H., Stoscheck, C., & Chinkers, M. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68224-4 · Cited by 776
Pinkas-Kramarski, R., Soussan, L., Waterman, H., Levkowitz, G., Alroy, I., Klapper, L., Lavi, S., Seger, R., Ratzkin, B. J., Sela, M., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00603.x · Cited by 769
Kornev, A. P., Haste, N. M., Taylor, S. S., & Ten Eyck, L. F. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607656103 · Cited by 762
Sirotnak, F. M., Zakowski, M. F., Miller, V. A., Scher, H. I., & Kris, M. G. (2000) · PubMed · Cited by 761
Zou, H. Y., Li, Q., Lee, J. H., Arango, M. E., McDonnell, S. R., Yamazaki, S., Koudriakova, T. B., Alton, G., Cui, J. J., Kung, P.-P., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4443 · Cited by 745
Druker, B. J., & Lydon, N. B. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9083 · Cited by 707
Linn, T. C., Pettit, F. H., & Reed, L. J. (1969) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.62.1.234 · Cited by 671
Christensen, J. G., Zou, H. Y., Arango, M. E., Li, Q., Lee, J. H., McDonnell, S. R., Yamazaki, S., Alton, G. R., Mroczkowski, B., & Los, G. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0365 · Cited by 649
Structural Basis for the Autoinhibition and STI-571 Inhibition of c-Kit Tyrosine Kinase
Mol, C. D., Dougan, D. R., Schneider, T. R., Skene, R. J., Kraus, M. L., Scheibe, D. N., Snell, G. P., Zou, H., Sang, B.-C., & Wilson, K. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403319200 · Cited by 635
A. THE ROLE OF CYCLIC-3',5'-AMP IN RESPONSES TO CATECHOLAMINES AND OTHER HORMONES
Sutherland, E. W., & Robison, G. A. (1966) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07116-9 · Cited by 612
Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors
Roskoski, R. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.01.003 · Cited by 607
Self-citationZheng, J., Knighton, D. R., Ten Eyck, L. F., Karlsson, R., Xuong, N., Taylor, S. S., & Sowadski, J. M. (1993) · Biochemistry · doi:10.1021/bi00060a005 · Cited by 589
THE ENZYMATIC PHOSPHORYLATION OF PROTEINS
Burnett, G., & Kennedy, E. P. (1954) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71184-8 · Cited by 582
Src kinase regulation by phosphorylation and dephosphorylation
Roskoski, R. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.012 · Cited by 577
Self-citationProtein kinase C, an elusive therapeutic target?
Mochly-Rosen, D., Das, K., & Grimes, K. V. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3871 · Cited by 563
Multiple evidence strands suggest that there may be as few as 19 000 human protein-coding genes
Ezkurdia, I., Juan, D., Rodriguez, J. M., Frankish, A., Diekhans, M., Harrow, J., Vazquez, J., Valencia, A., & Tress, M. L. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu309 · Cited by 549
Emerging roles of pseudokinases
Boudeau, J., Miranda-Saavedra, D., Barton, G. J., & Alessi, D. R. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.07.003 · Cited by 547
CONVERSION OF PHOSPHORYLASE b TO PHOSPHORYLASE a IN MUSCLE EXTRACTS
Fischer, E. H., & Krebs, E. G. (1955) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52289-x · Cited by 543
Carpenter, G., King, L., & Cohen, S. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30094-7 · Cited by 529
An activity phosphorylating tyrosine in polyoma T antigen immunoprecipitates
Eckhart, W., Hutchinson, M. A., & Hunter, T. (1979) · Cell · doi:10.1016/0092-8674(79)90205-8 · Cited by 525
Through the “Gatekeeper Door”: Exploiting the Active Kinase Conformation
Zuccotto, F., Ardini, E., Casale, E., & Angiolini, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901443h · Cited by 518
United States Food and Drug Administration Drug Approval Summary
Cohen, M. H., Williams, G. A., Sridhara, R., Chen, G., McGuinn, W. D., Morse, D., Abraham, S., Rahman, A., Liang, C., Lostritto, R., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0564 · Cited by 503
Hughes, T. P., Hochhaus, A., Branford, S., Müller, M. C., Kaeda, J. S., Foroni, L., Druker, B. J., Guilhot, F., Larson, R. A., O'Brien, S. G., et al. (2010) · Blood · doi:10.1182/blood-2010-03-273979 · Cited by 489
Assembly of allosteric macromolecular switches: lessons from PKA
Taylor, S. S., Ilouz, R., Zhang, P., & Kornev, A. P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3432 · Cited by 477
ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation
Shi, F., Telesco, S. E., Liu, Y., Radhakrishnan, R., & Lemmon, M. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002753107 · Cited by 471
Corbin, J. D., Sugden, P. H., West, L., Flockhart, D. A., Lincoln, T. M., & McCarthy, D. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34789-0 · Cited by 465
Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro
CARPENTER, G., KING, L., & COHEN, S. (1978) · Nature · doi:10.1038/276409a0 · Cited by 454
FDA Drug Approval Summary: Erlotinib (Tarceva®) Tablets
Cohen, M. H., Johnson, J. R., Chen, Y.-F., Sridhara, R., & Pazdur, R. (2005) · The Oncologist · doi:10.1634/theoncologist.10-7-461 · Cited by 445
A helix scaffold for the assembly of active protein kinases
Kornev, A. P., Taylor, S. S., & Ten Eyck, L. F. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807988105 · Cited by 442
Treatment of Non–Small-Cell Lung Cancer with Erlotinib or Gefitinib
Cataldo, V. D., Gibbons, D. L., Pérez-Soler, R., & Quintás-Cardama, A. (2011) · New England Journal of Medicine · doi:10.1056/nejmct0807960 · Cited by 418
Genetically lean mice result from targeted disruption of the RIIβ subunit of protein kinase A
Cummings, D. E., Brandon, E. P., Planas, J. V., Motamed, K., Idzerda, R. L., & McKnight, G. S. (1996) · Nature · doi:10.1038/382622a0 · Cited by 418
Shah, K., Liu, Y., Deirmengian, C., & Shokat, K. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3565 · Cited by 417
Activation of tyrosine kinases by mutation of the gatekeeper threonine
Azam, M., Seeliger, M. A., Gray, N. S., Kuriyan, J., & Daley, G. Q. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1486 · Cited by 411
Lin, C. R., Chen, W. S., Kruiger, W., Stolarsky, L. S., Weber, W., Evans, R. M., Verma, I. M., Gill, G. N., & Rosenfeld, M. G. (1984) · Science · doi:10.1126/science.6326261 · Cited by 403
The ErbB/HER receptor protein-tyrosine kinases and cancer
Roskoski, R. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.150 · Cited by 395
Self-citationThe Evolution of Protein Kinase Inhibitors from Antagonists to Agonists of Cellular Signaling
Dar, A. C., & Shokat, K. M. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-090308-173656 · Cited by 388
Cook, P. F., Neville, M. E., Vrana, K. E., Hartl, F. T., & Roskoski, R. (1982) · Biochemistry · doi:10.1021/bi00266a011 · Cited by 379
Self-citationKinase Drug Discovery – What’s Next in the Field?
Cohen, P., & Alessi, D. R. (2013) · ACS Chemical Biology · doi:10.1021/cb300610s · Cited by 377
RAF protein-serine/threonine kinases: Structure and regulation
Roskoski, R. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.07.092 · Cited by 376
Self-citationSpecific Targeted Therapy of Chronic Myelogenous Leukemia with Imatinib
Deininger, M. W. N., & Druker, B. J. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.4 · Cited by 365
Seger, R., Ahn, N. G., Posada, J., Munar, E. S., Jensen, A. M., Cooper, J. A., Cobb, M. H., & Krebs, E. G. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49722-6 · Cited by 364
Rapid protein kinase assay using phosphocellulose-paper absorption
Witt, J. J., & Roskoski, R. (1975) · Analytical Biochemistry · doi:10.1016/0003-2697(75)90743-5 · Cited by 355
Self-citationStructure and regulation of Kit protein-tyrosine kinase—The stem cell factor receptor
Roskoski, R. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.150 · Cited by 345
Self-citationTargeting Cyclin-Dependent Kinases in Human Cancers: From Small Molecules to Peptide Inhibitors
Peyressatre, M., Prével, C., Pellerano, M., & Morris, M. (2015) · Cancers · doi:10.3390/cancers7010179 · Cited by 344
Dynamics of the Ras/ERK MAPK Cascade as Monitored by Fluorescent Probes
Fujioka, A., Terai, K., Itoh, R. E., Aoki, K., Nakamura, T., Kuroda, S., Nishida, E., & Matsuda, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509344200 · Cited by 340
Cyclic Nucleotide-dependent Protein Kinases
Kuo, J. F., & Greengard, P. (1970) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63097-2 · Cited by 335
Boonstra, J., Rijken, P., Humbel, B., Cremers, F., Verkleij, A., & en Henegouwen, P. V. B. (1995) · Cell Biology International · doi:10.1006/cbir.1995.1086 · Cited by 335
Afatinib: First Global Approval
Dungo, R. T., & Keating, G. M. (2013) · Drugs · doi:10.1007/s40265-013-0111-6 · Cited by 329
Czernilofsky, A. P., Levinson, A. D., Varmus, H. E., Bishop, J. M., Tischer, E., & Goodman, H. M. (1980) · Nature · doi:10.1038/287198a0 · Cited by 321
Factors underlying sensitivity of cancers to small-molecule kinase inhibitors
Jänne, P. A., Gray, N., & Settleman, J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2871 · Cited by 303
Anaplastic lymphoma kinase (ALK): Structure, oncogenic activation, and pharmacological inhibition
Roskoski, R. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2012.11.007 · Cited by 303
Self-citationWiner, E., Gralow, J., Diller, L., Karlan, B., Loehrer, P., Pierce, L., Demetri, G., Ganz, P., Kramer, B., Kris, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.2134 · Cited by 293
Evidence for a second isoform of the catalytic subunit of cAMP-dependent protein kinase.
Uhler, M. D., Chrivia, J. C., & McKnight, G. S. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)66717-1 · Cited by 285
Cancer Drugs in the United States: Justum Pretium—The Just Price
Kantarjian, H. M., Fojo, T., Mathisen, M., & Zwelling, L. A. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.1845 · Cited by 284
MEK1/2 dual-specificity protein kinases: Structure and regulation
Roskoski, R. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.11.145 · Cited by 276
Self-citationMechanism-based cancer therapy: resistance to therapy, therapy for resistance
Ramos, P., & Bentires-Alj, M. (2015) · Oncogene · doi:10.1038/onc.2014.314 · Cited by 272
Bypass Mechanisms of Resistance to Receptor Tyrosine Kinase Inhibition in Lung Cancer
Niederst, M. J., & Engelman, J. A. (2013) · Science Signaling · doi:10.1126/scisignal.2004652 · Cited by 263
Corbin, A. S., Rosée, P. L., Stoffregen, E. P., Druker, B. J., & Deininger, M. W. (2003) · Blood · doi:10.1182/blood-2002-12-3659 · Cited by 258
A Raf-induced allosteric transition of KSR stimulates phosphorylation of MEK
Brennan, D. F., Dar, A. C., Hertz, N. T., Chao, W. C. H., Burlingame, A. L., Shokat, K. M., & Barford, D. (2011) · Nature · doi:10.1038/nature09860 · Cited by 254
Assay of protein kinases using radiolabeled ATP: a protocol
Hastie, C. J., McLauchlan, H. J., & Cohen, P. (2006) · Nature Protocols · doi:10.1038/nprot.2006.149 · Cited by 251
CaMKII inhibitors: from research tools to therapeutic agents
Pellicena, P., & Schulman, H. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00021 · Cited by 234
Evolution of the eukaryotic protein kinases as dynamic molecular switches
Taylor, S. S., Keshwani, M. M., Steichen, J. M., & Kornev, A. P. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0054 · Cited by 233
Resistance to Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors
Gramza, A. W., Corless, C. L., & Heinrich, M. C. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0190 · Cited by 226
ALK Inhibition for Non-Small Cell Lung Cancer: From Discovery to Therapy in Record Time
Gerber, D. E., & Minna, J. D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.033 · Cited by 220
ErbB/HER protein-tyrosine kinases: Structures and small molecule inhibitors
Roskoski, R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.06.001 · Cited by 218
Self-citationBarker, W. C., & Dayhoff, M. O. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.9.2836 · Cited by 216
Johnson, D. B., Flaherty, K. T., Weber, J. S., Infante, J. R., Kim, K. B., Kefford, R. F., Hamid, O., Schuchter, L., Cebon, J., Sharfman, W. H., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.3535 · Cited by 216
Deciphering the Structural Basis of Eukaryotic Protein Kinase Regulation
Meharena, H. S., Chang, P., Keshwani, M. M., Oruganty, K., Nene, A. K., Kannan, N., Taylor, S. S., & Kornev, A. P. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001680 · Cited by 208
Protein kinase biochemistry and drug discovery
Schwartz, P. A., & Murray, B. W. (2011) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2011.07.004 · Cited by 201
AKAP signaling complexes: getting to the heart of the matter
McConnachie, G., Langeberg, L. K., & Scott, J. D. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.05.008 · Cited by 200
A Genomic Analysis of Rat Proteases and Protease Inhibitors
Puente, X. S., & López-Otín, C. (2004) · Genome Research · doi:10.1101/gr.1946304 · Cited by 192
Taylor, S. S., Radzio‐Andzelm, E., & Hunter, T. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.13.7557015 · Cited by 188
Mizuno, K., Okano, I., Ohashi, K., Nunoue, K., Kuma, K., Miyata, T., & Nakamura, T. (1994) · PubMed · Cited by 187
Variation on an Src-like Theme
Harrison, S. C. (2003) · Cell · doi:10.1016/s0092-8674(03)00196-x · Cited by 186
Cancer Chemotherapy and Biotherapy : Principles and Practice
Burney, I. (2011) · Sultan Qaboos University Medical Journal · doi:10.18295/2075-0528.1308 · Cited by 185
Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia
Soverini, S., Branford, S., Nicolini, F. E., Talpaz, M., Deininger, M. W. N., Martinelli, G., Müller, M. C., Radich, J. P., & Shah, N. P. (2014) · Leukemia Research · doi:10.1016/j.leukres.2013.09.011 · Cited by 185
Structure and Allostery of the PKA RIIβ Tetrameric Holoenzyme
Zhang, P., Smith-Nguyen, E. V., Keshwani, M. M., Deal, M. S., Kornev, A. P., & Taylor, S. S. (2012) · Science · doi:10.1126/science.1213979 · Cited by 171
Day of the dead: pseudokinases and pseudophosphatases in physiology and disease
Reiterer, V., Eyers, P. A., & Farhan, H. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.03.008 · Cited by 170
Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Bernt, K. M., & Hunger, S. P. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00054 · Cited by 169
HIV-1 reverse transcriptase and antiviral drug resistance. Part 1
Das, K., & Arnold, E. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.03.012 · Cited by 168
Inactivation and Activation of Liver Phosphorylase
SUTHERLAND, E. W., & WOSILAIT, W. D. (1955) · Nature · doi:10.1038/175169a0 · Cited by 163
Cowan-Jacob, S., Guez, V., Fendrich, G., Griffin, J., Fabbro, D., Furet, P., Liebetanz, J., Mestan, J., & Manley, P. (2004) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557043487321 · Cited by 163
KRAS and BRAF: drug targets and predictive biomarkers
Vakiani, E., & Solit, D. B. (2011) · The Journal of Pathology · doi:10.1002/path.2796 · Cited by 162
A molecular gate which controls unnatural ATP analogue recognition by the tyrosine kinase v-Src
Liu, Y., Shah, K., Yang, F., Witucki, L. A., & Shokat, K. M. (1998) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(98)00099-6 · Cited by 156
Molecular Basis for Regulatory Subunit Diversity in cAMP-Dependent Protein Kinase
Diller, T. C., Madhusudan, Xuong, N., & Taylor, S. S. (2001) · Structure · doi:10.1016/s0969-2126(00)00556-6 · Cited by 152
AKAP signaling complexes: pointing towards the next generation of therapeutic targets?
Esseltine, J. L., & Scott, J. D. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.10.005 · Cited by 142
Zoller, M. J., & Taylor, S. S. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86899-0 · Cited by 140
Interconvertible Enzyme Cascades in Metabolic Regulation
Stadtman, E. R., & Chock, P. B. (1978) · Current topics in cellular regulation · doi:10.1016/b978-0-12-152813-3.50007-0 · Cited by 134
Hu, J., Yu, H., Kornev, A. P., Zhao, J., Filbert, E. L., Taylor, S. S., & Shaw, A. S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102554108 · Cited by 133
Botting, R. M. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70308-x · Cited by 129
Corrections to the nucleotide sequence of the src gene of Rous sarcoma virus
Czernilofsky, A. P., Levinson, A. D., VARMUS, H. E., Bishop, J. M., Tischer, E., & Goodman, H. M. (1983) · Nature · doi:10.1038/301736b0 · Cited by 124
Amieux, P. S., Howe, D. G., Knickerbocker, H., Lee, D. C., Su, T. T., Laszlo, G. S., Idzerda, R. L., & McKnight, G. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200302200 · Cited by 120
SERINEPHOSPHORIC ACID OBTAINED ON HYDROLYSIS OF VITELLINIC ACID
Lipmann, F. A., & Levene, P. A. (1932) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)76142-5 · Cited by 119
Michaud, V., Bar-Magen, T., Turgeon, J., Flockhart, D. A., Desta, Z., & Wainberg, M. A. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005553 · Cited by 117
The EGF receptor: structure, regulation and potential role in malignancy.
Thompson, D. M., & Gill, G. N. (1985) · PubMed · Cited by 116
Philadelphia chromosome‐positive acute lymphoblastic leukemia
Lee, H. J., Thompson, J. E., Wang, E. S., & Wetzler, M. (2010) · Cancer · doi:10.1002/cncr.25690 · Cited by 113
FEEDING EXPERIMENTS WITH MIXTURES OF HIGHLY PURIFIED AMINO ACIDS
McCoy, R. H., Meyer, C. E., & Rose, W. C. (1935) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)74986-7 · Cited by 112
STI-571: an anticancer protein-tyrosine kinase inhibitor
Roskoski, R. J. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.08.055 · Cited by 112
Self-citation1001 Protein Kinases Redux—Towards 2000
Hunter, T. (1994) · Seminars in Cell Biology · doi:10.1006/scel.1994.1044 · Cited by 104
HIV-1 reverse transcriptase and antiviral drug resistance. Part 2
Das, K., & Arnold, E. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.03.014 · Cited by 100
Kudchadkar, R. R., Paraiso, K. H. T., & Smalley, K. S. M. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e31824b436e · Cited by 95
Phosphoryl Transfer by Protein Kinase A Is Captured in a Crystal Lattice
Bastidas, A. C., Deal, M. S., Steichen, J. M., Guo, Y., Wu, J., & Taylor, S. S. (2013) · Journal of the American Chemical Society · doi:10.1021/ja312237q · Cited by 91
Participation of ADP Dissociation in the Rate-Determining Step in cAMP-Dependent Protein Kinase
Zhou, J., & Adams, J. A. (1997) · Biochemistry · doi:10.1021/bi971438n · Cited by 83
PKA signaling drives mammary tumorigenesis through Src
Beristain, A. G., Molyneux, S. D., Joshi, P. A., Pomroy, N. C., Grappa, M. A. D., Chang, M. C., Kirschner, L. S., Privé, G. G., Pujana, M. Á., & Khokha, R. (2014) · Oncogene · doi:10.1038/onc.2014.41 · Cited by 83
Drug discovery and the human kinome: Recent trends
Eglen, R. M., & Reisine, T. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.007 · Cited by 80
Mouse models of altered protein kinase A signaling
Kirschner, L. S., Yin, Z., Jones, G. N., & Mahoney, E. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0068 · Cited by 78
SERINEPHOSPHORIC ACID OBTAINED ON HYDROLYSIS OF VITELLINIC ACID. II
Levene, P. A., & Schormüller, A. (1933) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)75833-x · Cited by 77
Schreyer, S. A., Cummings, D. E., McKnight, G. S., & LeBoeuf, R. C. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2555 · Cited by 76
Chronic Myeloid Leukemia: Mechanisms of Resistance and Treatment
Jabbour, E., Parikh, S. A., Kantarjian, H., & Cortes, J. (2011) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2011.09.004 · Cited by 68
Protein Kinase A Effects of an Expressed PRKAR1A Mutation Associated with Aggressive Tumors
Meoli, E., Bossis, I., Cazabat, L., Mavrakis, M., Horvath, A., Stergiopoulos, S., Shiferaw, M. L., Fumey, G., Perlemoine, K., Muchow, M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0064 · Cited by 63
Adams, J. A., & Taylor, S. S. (1993) · Protein Science · doi:10.1002/pro.5560021217 · Cited by 61
Current and future management of Ph/BCR-ABL positive ALL
Maino, E., Sancetta, R., Viero, P., Imbergamo, S., Scattolin, A. M., Vespignani, M., & Bassan, R. (2014) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2014.895669 · Cited by 49
GI Stromal Tumors: 15 Years of Lessons From a Rare Cancer
Cioffi, A., & Maki, R. G. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.7344 · Cited by 48
Bishop, J. S., & Larner, J. (1969) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(69)90176-4 · Cited by 47
Afatinib for the treatment of metastatic non-small cell lung cancer
Joshi, M., Rizvi, S., & Belani, C. P. (2015) · Cancer Management and Research · doi:10.2147/cmar.s51808 · Cited by 44
Enns, L. C., Morton, J. F., Mangalindan, R., McKnight, G. S., Schwartz, M. W., Kaeberlein, M. R., Kennedy, B. K., Rabinovitch, P. S., & Ladiges, W. (2009) · The Journals of Gerontology Series A · doi:10.1093/gerona/glp133 · Cited by 43
Cheadle, C., Nesterova, M., Watkins, T., Barnes, K. C., Hall, J. C., Rosen, A., Becker, K. G., & Cho‐Chung, Y. S. (2008) · BMC Medical Genomics · doi:10.1186/1755-8794-1-43 · Cited by 41
Roskoski, R. J. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.813015 · Cited by 39
Self-citationGetting Around PLX4032: Studies Turn Up Unusual Mechanisms of Resistance to Melanoma Drug
Tuma, R. S. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr016 · Cited by 13
Selection of Therapy: Rational Decisions Based on Molecular Events
Khorashad, J. S., & Deininger, M. W. (2011) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2011.09.006 · Cited by 8
Cited by
Roskoski, R. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2015.10.021 · Cited by 886
Self-citationTrends in kinase drug discovery: targets, indications and inhibitor design
Attwood, M. M., Fabbro, D., Sokolov, A. V., Knapp, S., & Schiöth, H. B. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00252-y · Cited by 779
Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update
Roskoski, R. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2019.104609 · Cited by 559
Self-citationProperties of FDA-approved small molecule protein kinase inhibitors
Roskoski, R. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.03.006 · Cited by 554
Self-citationRoskoski, R. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.014 · Cited by 487
Self-citation
Metadata
- Authors
- Roskoski, R.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2015-10
- Volume
- 100
- Pages
- 1-23
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W1881469793
- Cited by
- 526
- References
- 173
- FWCI
- 17.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.